Literature DB >> 6124580

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients.

A M Ghadirian, G Chouinard, L Annable.   

Abstract

A random sample of 55 schizophrenic outpatients, 26 men and 29 women, treated with neuroleptics was selected from our long term follow-up clinic. The patients rated their current sexual functioning on specially designed scales. Fifty-four per cent of male and 30 per cent of female patients reported impaired sexual functioning during neuroleptic treatment. Ninety-one per cent of female patients reported changes in menstruation. Partial correlation coefficients were calculated between sexual dysfunction score and plasma prolactin level adjusting for age. Sexual dysfunction was found to be associated with high plasma prolactin levels in male patients but not in female patients. High prolactin tended also to be associated with menstrual disturbances. Antiparkinsonian medication was not found to be correlated with either sexual dysfunction or menstrual disorder score.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124580     DOI: 10.1097/00005053-198208000-00004

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  26 in total

1.  Hyperprolactinaemia caused by antipsychotic drugs.

Authors:  Angelika Wieck; Peter Haddad
Journal:  BMJ       Date:  2002-02-02

Review 2.  Dose response and atypical antipsychotics in schizophrenia.

Authors:  Bruce J Kinon; Jonna Ahl; Virginia L Stauffer; Angela L Hill; Peter F Buckley
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 3.  The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.

Authors:  Marrit K de Boer; Stynke Castelein; Durk Wiersma; Robert A Schoevers; Henderikus Knegtering
Journal:  Schizophr Bull       Date:  2015-02-25       Impact factor: 9.306

4.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

Review 5.  Questionnaires to measure sexual quality of life.

Authors:  Renata Arrington; Joseph Cofrancesco; Albert W Wu
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

6.  Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses.

Authors:  Jill M Goldstein; Katie Lancaster; Julia M Longenecker; Brandon Abbs; Laura M Holsen; Sara Cherkerzian; Susan Whitfield-Gabrieli; Nicolas Makris; Ming T Tsuang; Stephen L Buka; Larry J Seidman; Anne Klibanski
Journal:  Psychiatry Res       Date:  2015-03-31       Impact factor: 3.222

7.  Sexual development and life of psychiatric female patients.

Authors:  J Raboch
Journal:  Arch Sex Behav       Date:  1986-08

Review 8.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.

Authors:  Anil Kumar M Nagaraj; Nagesh B Pai; Satheesh Rao
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.